BAXTER INTERNATIONAL INC acquired Sera-Tec Biologicals, L.P. for $127M, a transaction completed in February 2001, structured as Acquisition paid in 2,894,710 shares of Baxter common stock.
Sera-Tec Biologicals, L.P. operates in BioScience, is based in United States. Baxter acquired Sera-Tec Biologicals, which owned and operated 80 plasma-collection centers across 28 states along with a central testing laboratory. The acquisition secured plasma-collection capacity to support Baxter's plasma-based therapies within its BioScience business.
Secured a network of plasma-collection centers and testing capacity to supply Baxter's plasma-based therapies.
Advisory firms were not disclosed for this transaction.